French biotech EG 427 has had success with its urinary incontinence DNA therapy, EG110A, showing a more than 80% reduction in ...

HSV is currently in 13th place, which they could be quite content with at the end of the season. However, Stefan Kuntz ...

However, Ulreich failed to impress and returned to Munich. Heuer Fernandes returned between the posts, before having to make ...

Matthew Taylor likened his recently published work alongside doctoral student Gary Dunn to kicking over a rock. Once the ...

As in previous seasons, we’ll highlight 10 players to consider adding to your Fantasy Bundesliga team ahead of each ...

Over 88% reduction in urinary incontinence episodes achieved in low dose cohort at 12 weeksGood tolerability with no systemic side effectsFirst DNA medicine to selectively target, at the local level, ...

Three Canadian stocks to watch The TSX continues its impressive rally into October, setting fresh record highs and building ...

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...

Researchers David Chu and Uma Singh have developed and patented a new molecule named POM-L-BHDU. This molecule has shown ...

The winner of the inaugural Player of the Month Award, courtesy of FeartheWall, is Karim Adeyemi. Continuing his solid run of form from the latter half of the last season, Adeyemi has been steadily ...

The vaccine has virtually eliminated childhood infections of a disease that doesn’t only transmit through drugs or sex.

Our ancient past isn't always buried history. When it comes to our DNA, nearly 9% of the human genome is made up of leftover ...